skr加速器2024年-快连加速器app
In March, laboratory-based research at Harvard was put on hold, maintaining only the most critical functions to safeguard materials that are essential to our mission of finding cures and better treatments for human disease. In May, the university announced its research laboratory re-entry plan, and has been preparing for re-entry in fidelity with federal, state, local and university policy and requirements. Visit the Harvard University coronavirus website for university-wide information, and the ISSCR coronavirus page for stem-cell community resources.
skr加速器2024年-快连加速器app
bluelight翻墙
Read more about HSCI
Research
HSCI bridges the gaps in traditional research funding to encourage bold thinking and launch scientific careers.
Through our disease programs, we channel world-class resources, both intellectual and technological, toward some of the most prevalent, devastating diseases for which stem cell research holds promise.
In addition, our seed grants and junior faculty programs provide funding for innovative, early-stage projects in stem cell research. This allows up-and-coming scientists to pursue "high risk/high reward" avenues of research that might be difficult to fund from other sources.
- Blood Diseases
- bluelight翻墙
- Cardiovascular Diseases
- Diabetes
- bluelight翻墙
- Musculoskeletal Disease
- Nervous System Diseases
- Skin Diseases
- Fibrosis & Aging
- Stem Cells as Tools
All Research Areas
bluelight下载
Protecting beta cells against type 1 diabetes
bluelight安卓版
Gut microbiome influences ALS outcomes
HSCI scientists identify gut-brain connection in ALS
skr加速器2024年-快连加速器app
HSCI Faculty
HSCI has been breaking down barriers to collaboration in stem cell science since 2004. We provide fertile ground for more than 350 research faculty and their labs, across the university’s schools, centers, teaching hospitals, and partner companies, to share knowledge and pursue bold new ideas.
With Harvard as a wellspring of discovery and a strong network that embraces new ways of working, we are better equipped than ever to change human health in ways that will benefit all of society.
Executive Committee
skr加速器2024年-快连加速器app
bluelight翻墙
From Lab to Clinic
skr加速器2024年-快连加速器app
A key part of our mission is to move research out of the lab and into the clinic. Since our founding, we have been forging a clear path to translating discoveries into products that benefit patients. Now, we have the flexibility to organize people across institutions and sectors to tackle specific biological problems so we can make a lasting difference in people's lives.
bluelight安卓版
bluelight翻墙
Stem-cell research news delivered straight to your inbox.
Sign up for the HSCI monthly newsletter
Subscribe